Suppression of the nuclear factor Eny2 increases insulin secretion in poorly functioning INS-1E insulinoma cells

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Dames, P ^a   Weise, M ^a   Puff, R ^a   Goke B ^a   Parhofer, K G ^a   Seissler, J ^a   Lechner, A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; EXENDIN 4; GLUCOSE; INCRETIN; NUCLEAR FACTOR; PROTEIN ENY2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ENY2 PROTEIN, MOUSE; ENY2 PROTEIN, RAT; INSULIN; MESSENGER RNA; PEPTIDE; TRANSCRIPTION FACTOR; VENOM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; ENY2 GENE; FEMALE; GENE; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; INSULIN RELEASE; INSULINOMA; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL LINE; CELL NUCLEUS; METABOLISM; RAT; SECRETION (PROCESS);

ANIMALS; CELL LINE; CELL NUCLEUS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; GLUCOSE; INSULIN; INSULINOMA; MICE; MICE, INBRED C57BL; PEPTIDES; RATS; RNA, MESSENGER; TRANSCRIPTION FACTORS; VENOMS;

EID: 84862297273     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/460869     Document Type: Article

References (19)

1. Gerich J. E., Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus Mayo Clinic Proceedings 2003 78 4 447 456 (Pubitemid 36373946)
2. Kahn S. E., Zraika S., Utzschneider K. M., Hull R. L., The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality Diabetologia 2009 52 6 1003 1012
3. Voight B. F., Scott L. J., Steinthorsdottir V., Morris A. P., Dina C., Welch R. P., Zeggini E., Huth C., Aulchenko Y. S., Thorleifsson G., McCulloch L. J., Ferreira T., Grallert H., Amin N., Wu G., Willer C. J., Raychaudhuri S., McCarroll S. A., Langenberg C., Hofmann O. M., Dupuis J., Qi L., Segr A. V., Van Hoek M., Navarro P., Ardlie K., Balkau B., Benediktsson R., Bennett A. J., Blagieva R., Boerwinkle E., Bonnycastle L. L., Bostrm K. B., Bravenboer B., Bumpstead S., Burtt N. P., Charpentier G., Chines P. S., Cornelis M., Couper D. J., Crawford G., Doney A. S. F., Elliott K. S., Elliott A. L., Erdos M. R., Fox C. S., Franklin C. S., Ganser M., Gieger C., Grarup N., Green T., Griffin S., Groves C. J., Guiducci C., Hadjadj S., Hassanali N., Herder C., Isomaa B., Jackson A. U., Johnson P. R. V., Jrgensen T., Kao W. H. L., Klopp N., Kong A., Kraft P., Kuusisto J., Lauritzen T., Li M., Lieverse A., Lindgren C. M., Lyssenko V., Marre M., Meitinger T., Midthjell K., Morken M. A., Narisu N., Nilsson P., Owen K. R., Payne F., Perry J. R. B., Petersen A. K., Platou C., Proena C., Prokopenko I., Rathmann W., Rayner N. W., Robertson N. R., Rocheleau G., Roden M., Sampson M. J., Saxena R., Shields B. M., Shrader P., Sigurdsson G., Spars T., Strassburger K., Stringham H. M., Sun Q., Swift A. J., Thorand B., Tichet J., Tuomi T., Van Dam R. M., Van Haeften T. W., Van Herpt T., Van Vliet-Ostaptchouk J. V., Walters G. B., Weedon M. N., Wijmenga C., Witteman J., Bergman R. N., Cauchi S., Collins F. S., Gloyn A. L., Gyllensten U., Hansen T., Hide W. A., Hitman G. A., Hofman A., Hunter D. J., Hveem K., Laakso M., Mohlke K. L., Morris A. D., Palmer C. N. A., Pramstaller P. P., Rudan I., Sijbrands E., Stein L. D., Tuomilehto J., Uitterlinden A., Walker M., Wareham N. J., Watanabe R. M., Abecasis G. R., Boehm B. O., Campbell H., Daly M. J., Hattersley A. T., Hu F. B., Meigs J. B., Pankow J. S., Pedersen O., Wichmann H. E., Barroso I., Florez J. C., Frayling T. M., Groop L., Sladek R., Thorsteinsdottir U., Wilson J. F., Illig T., Froguel P., Van Duijn C. M., Stefansson K., Altshuler D., Boehnke M., McCarthy M. I., Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis Nature Genetics 2010 42 7 579 589
4. Leahy J. L., Hirsch I. B., Peterson K. A., Schneider D., Targeting -cell function early in the course of therapy for type 2 diabetes mellitus Journal of Clinical Endocrinology and Metabolism 2010 95 9 4206 4216
5. Zhao Y., Lang G., Ito S., Bonnet J., Metzger E., Sawatsubashi S., Suzuki E., Le Guezennec X., Stunnenberg H. G., Krasnov A., Georgieva S. G., Schle R., Takeyama K. I., Kato S., Tora L., Devys D., A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing Molecular Cell 2008 29 1 92 101
6. Jani D., Lutz S., Marshall N. J., Fischer T., Khler A., Ellisdon A. M., Hurt E., Stewart M., Sus1, Cdc31, and the Sac3 CID region form a conserved interaction platform that promotes nuclear pore association and mRNA export Molecular Cell 2009 33 6 727 737
7. Kopytova D. V., Orlova A. V., Krasnov A. N., Gurskiy D. Y., Nikolenko J. V., Nabirochkina E. N., Shidlovskii Y. V., Georgieva S. G., Multifunctional factor ENY2 is associated with the THO complex and promotes its recruitment onto nascent mRNA Genes and Development 2010 24 1 86 96
8. Kurshakova M., Maksimenko O., Golovnin A., Pulina M., Georgieva S., Georgiev P., Krasnov A., Evolutionarily conserved E(y)2/Sus1 protein is essential for the barrier activity of Su(Hw)-dependent insulators in Drosophila Molecular Cell 2007 27 2 332 338 (Pubitemid 47058301)
9. Kopytova D. V., Krasnov A. N., Orlova A. V., Gurskiy D. Y., Nabirochkina E. N., Georgieva S. G., Shidlovskii Y. V., Eny2: couple, triple...more? Cell Cycle 2010 9 3 479 481
10. Puff R., Dames P., Weise M., Gke B., Parhofer K. G., Lechner A., No non-redundant function of suppressor of cytokine signaling 2 in insulin producing -cells Islets 2010 2 4 252 257
11. Merglen A., Theander S., Rubi B., Chaffard G., Wollheim C. B., Maechler P., Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells Endocrinology 2004 145 2 667 678 (Pubitemid 38183809)
12. Janjic D., Wollheim C. B., Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay Diabetologia 1992 35 5 482 485
13. Jitrapakdee S., Wutthisathapornchai A., Wallace J. C., MacDonald M. J., Regulation of insulin secretion: role of mitochondrial signalling Diabetologia 2010 53 6 1019 1032
14. Segu V. B. G., Li G., Metz S. A., Use of a soluble tetrazolium compound to assay metabolic activation of intact cells Metabolism 1998 47 7 824 830 (Pubitemid 28313189)
15. Holst J. J., Gromada J., Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans American Journal of PhysiologyEndocrinology and Metabolism 2004 287 2 E199 E206
16. Holz G. G., Epac: a new camp-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic -cell Diabetes 2004 53 1 5 13 (Pubitemid 38044691)
17. Hohmeier H. E., Mulder H., Chen G., Henkel-Rieger R., Prentki M., Newgard C. B., Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion Diabetes 2000 49 3 424 430 (Pubitemid 30131788)
18. Lu D., Mulder H., Zhao P., Burgess S. C., Jensen M. V., Kamzolova S., Newgard C. B., Sherry A. D., 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS) Proceedings of the National Academy of Sciences of the United States of America 2002 99 5 2708 2713 (Pubitemid 34240525)
19. Yang S., Fransson U., Fagerhus L., Holst L. S., Hohmeier H. E., Renstrm E., Mulder H., Enhanced cAMP protein kinase A signaling determines improved insulin secretion in a clonal insulin-producing -cell line (INS-1 832/13) Molecular Endocrinology 2004 18 9 2312 2320 (Pubitemid 39215259)